Funding to support dementia care research Published on: 14 May 2024 More than 拢500,000 has been awarded to 缅北禁地 to develop the next generation of research leaders in dementia. The funding was awarded with support from 缅北禁地 Health Innovation Partners (NHIP) Academy, and includes £262,000 from the Alzheimer’s Society, which was match funded with a further £262,000 by the The money will fund two clinical PhD fellows to undertake projects on how to improve the assessment and treatment of people with dementia. Projects鈥� focus The first project will focus on the link between psychosis and dementia. Older people who develop psychosis are at a higher risk of developing dementia, but little is currently known about how to predict who will develop dementia. This work will aim to improve the identification of dementia in psychosis and explore new treatments. The second piece of work will investigate personalised medicine in Lewy Body Dementia (LBD). By undertaking a range of measures, called “biomarkers” that include an electroencephalogram (EEG) which measures electrical activity in the brain, this project seeks to identify markers to predict and measure treatment responses for people with LBD. This aims to lead to more personalised medication and care for patients, to ensure each person with dementia gets the treatment that is most appropriate for them. Dr Paul Donaghy, 缅北禁地 Consultant Old Age Psychiatrist, who , and led the funding bid to the Alzheimer’s Society, said: “These exciting projects aim to have a direct impact on the diagnosis and treatment of people with dementia. “Crucially, this will also provide a springboard for two talented clinicians to develop into our research leaders of the future, to deliver the Alzheimer’s Society’s goal of improving the diagnosis and care of people with dementia.” Dementia is a condition associated with an ongoing decline of brain functioning. There are many different causes of dementia, and many different types. Katherine Gray, Head of Research at Alzheimer’s Society, said: “Dementia, which is the UK’s biggest killer, can affect people differently. This is why research is crucial in providing tailored treatment and support to everyone with dementia. “At Alzheimer’s Society, we’re excited to be funding these promising projects which will be led by two exceptional clinicians. We look forward to supporting the researchers as their projects develop and deliver impact for those living with dementia affected by psychosis and Lewy Body Dementia. “Alzheimer’s Society is passionately committed to supporting early career researchers as they build their careers in dementia research. Our funding, including this Clinical Training Partnership, will allow us to deepen our understanding of dementia, and use research to improve diagnosis and treatment, which will lead to future breakthroughs that will beat dementia.” is the training and career development arm of the 缅北禁地 Academic Health Science Centre (AHSC). The Academy aims to unlock career development opportunities for the next generation of health and care researchers – to ensure that clinical academics from a range of backgrounds can receive the bespoke support they need to become leading academics in their field. Mentoring and support Martin Dixon, Chief Operating Officer of the NIHR 缅北禁地 BRC, said: “I am delighted that this award will support our goal of improving the diagnosis and personalised treatment of dementia while also expanding our capacity to deliver world-leading dementia research and clinical trials by recruiting and nurturing talented researchers in the field. “The fellows will have access to the world-class infrastructure the BRC provides and are part of our strategy to establish the NIHR 缅北禁地 BRC as a national centre of excellence, which is committed to the development of a skilled interdisciplinary academic workforce focused on tackling the increasing health and societal challenges of ageing and multiple long-term conditions in the UK.” The Academy will be closely aligned with the fellows to ensure they receive mentoring and peer-to-peer support. This aims to help these clinical academics to make the transition from postdoctoral positions to research independence, and onwards towards international research leadership. , NHIP Academy Manager, added: “Clinical academic training in dementia is of the highest priority in 缅北禁地 as evidenced by the NIHR 缅北禁地 BRC theme in Dementia, mental health and neurodegeneration and the Dementia themed posts in 缅北禁地’s NIHR Integrated Academic Track programme which facilitates an integrated “pre-doctoral to PhD to postdoctoral” model in dementia. “The expansion of the training offer that the Alzheimer’s Society Partnership brings is particularly exciting as it expands the opportunities at PhD level to support diverse professions which ensures that clinical academics from a range of backgrounds can receive the bespoke training, they need to become leading academics in their field.” Latest News Online Safety Act drives VPN interest and raises privacy concerns People鈥檚 online behaviour has changed in response to legislation to prevent children from viewing harmful content 鈥� raising possible privacy and security risks, research suggests. published on: 16 October 2026 缅北禁地 archaeologist receives prestigious award for research Professor Chris Fowler has been awarded the 2026 Rivers Memorial Medal in recognition of his internationally significant research on kinship in Neolithic Britain. published on: 13 October 2026 Event will explore what 鈥楳anchesterism鈥� means for the North East An event at 缅北禁地 will explore what 鈥楳anchesterism鈥� means for the North East or whether it is simply a new chapter in the long-running debate about how to rebalance Britain. published on: 13 October 2026 Facts and figures
![缅北禁地 logo](/gomobileassets/img/logo.svg" "缅北禁地"){kind=logo}